FB2026_01 , released March 12, 2026
FB2026_01 , released March 12, 2026
Gene: Dmel\Egfr
Open Close
General Information
Symbol
Dmel\Egfr
Species
D. melanogaster
Name
Epidermal growth factor receptor
Annotation Symbol
CG10079
Feature Type
FlyBase ID
FBgn0003731
Gene Model Status
Stock Availability
Enzyme Name (EC)
receptor protein-tyrosine kinase (2.7.10.1)
Gene Summary
Epidermal growth factor receptor (Egfr) encodes the transmembrane tyrosine kinase receptor for signaling ligands (encoded by grk, spi, vn, and Krn) in the TGFα family, which utilises the intracellular MAP kinase pathway. The product of Egfr contributes to growth regulation, cell survival and developmental patterning. [Date last reviewed: 2019-06-06] (FlyBase Gene Snapshot)
Also Known As

DER, top, flb, Elp, dEGFR

Key Links
Genomic Location
Cytogenetic map
Sequence location
Recombination map
2-95
RefSeq locus
NT_033778 REGION:21522420..21559977
Sequence
Genomic Maps
Other Genome Views
The following external sites may use different assemblies or annotations than FlyBase.
Function
Gene Ontology (GO) Annotations (87 terms)
Molecular Function (6 terms)
Terms Based on Experimental Evidence (2 terms)
CV Term
Evidence
References
Terms Based on Predictions or Assertions (4 terms)
CV Term
Evidence
References
Biological Process (75 terms)
Terms Based on Experimental Evidence (71 terms)
CV Term
Evidence
References
inferred from mutant phenotype
inferred from mutant phenotype
inferred from genetic interaction with FLYBASE:Vav; FB:FBgn0040068
inferred from mutant phenotype
inferred from mutant phenotype
inferred from mutant phenotype
inferred from mutant phenotype
inferred from mutant phenotype
inferred from mutant phenotype
involved_in dorsal closure
inferred from mutant phenotype
inferred from mutant phenotype
inferred from genetic interaction with FLYBASE:Myc; FB:FBgn0262656
involved_in eye development
inferred from mutant phenotype
inferred from mutant phenotype
inferred from mutant phenotype
involved_in gonad development
inferred from mutant phenotype
inferred from mutant phenotype
involved_in heart process
inferred from mutant phenotype
inferred from mutant phenotype
inferred from genetic interaction with FLYBASE:Egfr; FB:FBgn0003731
inferred from mutant phenotype
inferred from mutant phenotype
inferred from mutant phenotype
inferred from genetic interaction with FLYBASE:hid; FB:FBgn0003997
inferred from genetic interaction with FLYBASE:rpr; FB:FBgn0011706
inferred from mutant phenotype
involved_in neurogenesis
inferred from genetic interaction with FLYBASE:Myc; FB:FBgn0262656
inferred from mutant phenotype
involved_in notum development
inferred from mutant phenotype
inferred from mutant phenotype
involved_in olfactory learning
inferred from mutant phenotype
inferred from mutant phenotype
inferred from mutant phenotype
inferred from mutant phenotype
inferred from mutant phenotype
inferred from mutant phenotype
inferred from mutant phenotype
inferred from direct assay
inferred from mutant phenotype
inferred from mutant phenotype
inferred from mutant phenotype
inferred from mutant phenotype
inferred from mutant phenotype
inferred from mutant phenotype
inferred from mutant phenotype
inferred from mutant phenotype
inferred from mutant phenotype
inferred from mutant phenotype
inferred from mutant phenotype
inferred from mutant phenotype
Terms Based on Predictions or Assertions (6 terms)
CV Term
Evidence
References
Cellular Component (6 terms)
Terms Based on Experimental Evidence (3 terms)
CV Term
Evidence
References
inferred from direct assay
colocalizes_with cytoneme
inferred from direct assay
located_in plasma membrane
inferred from high throughput direct assay
inferred from direct assay
Terms Based on Predictions or Assertions (4 terms)
CV Term
Evidence
References
inferred from biological aspect of ancestor with PANTHER:PTN000698827
located_in membrane
inferred from electronic annotation with InterPro:IPR016245
is_active_in plasma membrane
inferred from biological aspect of ancestor with PANTHER:PTN001230349
inferred from biological aspect of ancestor with PANTHER:PTN001230349
Gene Group (FlyBase)
Protein Family (UniProt)
Belongs to the protein kinase superfamily. Tyr protein kinase family. EGF receptor subfamily. (P04412)
Catalytic Activity (EC/Rhea)
transmembrane receptor protein tyrosine kinase activity
L-tyrosyl-[protein] + ATP = O-phospho-L-tyrosyl-[protein] + ADP + H(+) (2.7.10.1)
protein tyrosine kinase activity
RHEA 10596:
Summaries
Gene Snapshot
Epidermal growth factor receptor (Egfr) encodes the transmembrane tyrosine kinase receptor for signaling ligands (encoded by grk, spi, vn, and Krn) in the TGFα family, which utilises the intracellular MAP kinase pathway. The product of Egfr contributes to growth regulation, cell survival and developmental patterning. [Date last reviewed: 2019-06-06]
Pathway (FlyBase)
EGFR SIGNALING PATHWAY CORE COMPONENTS -
The Epidermal Growth Factor Receptor (EGFR) signaling pathway is used multiple times during development (FBrf0190321). It is activated by the binding of a secreted ligand to the receptor tyrosine kinase Egfr and acts via the canonical Ras/Raf/MAP kinase (ERK) cascade. (Adapted from FBrf0190321 and FBrf0221727).
Gene Group (FlyBase)
RECEPTOR TYROSINE KINASES -
Receptor tyrosine kinases (RTK) are single-pass transmembrane receptors expressed on the plasma membrane. Upon the binding of an extracellular signalling molecule (e.g. growth factors, hormones), RTKs dimerize leading to the activation of the intracellular tyrosine kinase domain and intermolecular phosphorylation. The phosphotyrosines function as specific sites for the assembly, phosphorylation and activation of downstream signaling molecules. (Adapted from PMID:20602996).
Protein Function (UniProtKB)
Receptor tyrosine kinase, binding ligands of the EGF family and activating several signaling cascades to convert extracellular cues into appropriate cellular responses (PubMed:22140578, PubMed:23579691, PubMed:8070664, PubMed:9882502). Known ligands include spitz, gurken, vein and giant-lens (PubMed:19718021, PubMed:20723758, PubMed:22140578, PubMed:9882502). Transduces the signal through the ras-raf-MAPK pathway (PubMed:9094709). Critical for the proliferation of imaginal tissues, and for the determination of both the antero-posterior and dorso-ventral polarities of the oocyte (PubMed:23579691, PubMed:34411095, PubMed:9882502). In the embryo, plays a role in the establishment of ventral cell fates, maintenance of amnioserosa and ventral neuroectodermal cells, germ band retraction, cell fate specification in the central nervous system, and production and repair of the cuticle (PubMed:22140578, PubMed:23029159, PubMed:23579691, PubMed:9094709). During dorsal closure (DC) functions with the dpp- and ACK-signaling pathways to regulate expression of the myosin zip in the embryonic epidermis and amnioserosa (AS), and thus coordinate the progression of epidermal cell shape changes required for correct DC (PubMed:23579691). In the embryonic epidermis, functions by negatively regulating dpp and consequently the dpp-dependent expression of the myosin zip (PubMed:23579691). In the AS, negatively regulates the production/ and or secretion of a diffusible signal which, is produced by the ACK-signaling pathway, and acts in the AS and epidermal cells to promote zip expression (PubMed:23579691). Also required in the AS to inhibit or delay apoptosis, and consequently slow the rate of DC (PubMed:23579691). Therefore functions at multiple levels to negatively regulate morphogenesis during DC, suggesting that it acts as a general brake mechanism for adjusting the rate of dorsal closure to ensure that closure proceeds smoothly and without loss of epidermal integrity (PubMed:23579691). During oogenesis, one of two tyrosine kinase chemoattractant receptors (Egfr and Pvr), that function in the border cells (BC) to detect guidance cues from the oocyte and transduce this information to the guidance pathway that regulate the collective migration of the BC cluster through the nurse cells to the oocyte (PubMed:24855950).
(UniProt, P04412)
Phenotypic Description (Red Book; Lindsley and Zimm 1992)
Egfr: Epidermal growth factor receptor homologue
Encodes the Drosophila homolog of epidermal growth factor receptor protein. Mutations with three different phenotypes and described under three different names shown to be alleles of Egfr. Elp (Ellipse) is a dominant eye shape and texture mutant; flb (faint little ball) is an embryonic lethal causing dorsalized embryos, and top (torpedo) is a maternal-effect lethal causing ventralized embryos; each of these classes is described in detail at the end of the entry; in situ hybridization with transcript-specific probes reveals uniform distribution of transcript during embryogenesis; in larvae, hybridization confined to mitotic tissues and not seen in cells with polytene chromosomes (Kammermeyer and Wadsworth, 1987, Development 100: 201-10). Transcript concentrated in cells of the central nervous system and gonial cells in adults.
EgfrE
Eyes of EgfrE/+ heterozygotes rough and more oval than wild type; also display a slight disturbance of the wing-vein pattern. Homozygotes have smaller eyes with many fewer ommatidia and some regions lack them entirely; those ommatidia that are formed contain the normal number and arrangement of cells; the regions without ommatidia contain cells that resemble pigment cells and mechanosensory bristles; only about one tenth the normal number of preommatidial cell clusters differentiate behind the morphogenetic furrow. EgfrE in heterozygous combination with a deficiency or null mutation for Egfr is normal in phenotype indicating that EgfrE alleles are hypermorphic.
Egfrf
Embryonic lethal. Embryos form a ball of dorsal hypoderm with the internal organs extruded anteriorly. Ventral cuticle absent or strongly reduced. First visible in extended-germ-band stage. Cells at the anterior and posterior ends of the embryo form clumps and slough off; very few head and gnathal cells remain. Substantial ectodermal cell death observed; germ band retraction fails to take place. Ultimately, cuticle formation produces mostly dorsal and lateral cuticular elements with but a narrow strip of denticles mid-ventrally. Hypomorphic alleles initiate but do not complete germ-band retraction; they show intermediate phenotypes with wider denticle bands and in weak alleles some head and telson structures are formed as well. No maternal effect as shown by pole-cell transplantation.
Egfrt
Maternal-effect lethal. Homozygous females lay eggs that are long and pointed at both ends. Such eggs often have only one fused dorsal appendage; also there is an increase in the number of follicle cells that give rise to the main body of the chorion at the expense of those ordinarily contributing to the operculum and dorsal appendages. Egfrt alleles are completely recessive and fully penetrant in homozygous females; the embryos never hatch. Homozygous and hemizygous adult flies exhibit incomplete fourth veins, absence of the anterior crossvein, rough eyes, loss of ocelli and ocellar bristles, and the loss of sensory bristles from the thorax. Changes in the embryonic pattern become visible at the beginning of gastrulation. Around the circumference of the embryo, 40% of the cells invaginate on the ventral side and form mesoderm; these cells become organized into two ventral furrows which are lost in later stages, and a mass of mesodermal cells fills the ventral half of the embryo. The only cuticle structure differentiated is a strip of dorsal hypoderm flanked by bands of ventral setae; lateral and ventral sides are made up of mesoderm. The head is reduced but filzkorper and spiracles are visible posteriorly. Experiments with germline mosaics produced by pole cell transplantation indicate that the mutant gives rise to ventralized eggs and embryos by interferring with processes taking place in somatic cells rather than germinal tissue. The mutant phenotype was only produced in mosaics in which wild-type germ cells were surrounded by Egfrt follicle cells and not by the reverse cell arrangement. Egfrt blocks dorsalization caused by fs(1)K10, but not that produced by dl females.
Summary (Interactive Fly)

transmembrane receptor tyrosine kinase for signaling ligands in the TGFα family (Gurken, Spitz, Vein, and Keren) - utilises the intracellular MAP kinase pathway - during oogenesis helps set up egg polarity, determines the identity of cells in the ectoderm - during larval stages participates in the development of the eye and wing - regulates growth, cell survival and developmental patterning

Gene Model and Products
Number of Transcripts
2
Number of Unique Polypeptides
2

Please see the JBrowse view of Dmel\Egfr for information on other features

To submit a correction to a gene model please use the Contact FlyBase form

Protein Domains (via Pfam)
Isoform displayed:
Pfam protein domains
InterPro name
classification
start
end
Protein Domains (via SMART)
Isoform displayed:
SMART protein domains
InterPro name
classification
start
end
Structure
Protein 3D structure   (Predicted by AlphaFold)   (AlphaFold entry P04412)

If you don't see a structure in the viewer, refresh your browser.
Model Confidence:
  • Very high (pLDDT > 90)
  • Confident (90 > pLDDT > 70)
  • Low (70 > pLDDT > 50)
  • Very low (pLDDT < 50)

AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. Some regions with low pLDDT may be unstructured in isolation.

Experimentally Determined Structures
Crossreferences
PDB - An information portal to biological macromolecular structures
Comments on Gene Model

Low-frequency RNA-Seq exon junction(s) not annotated.

Gene model reviewed during 5.51

Transcript Data
Annotated Transcripts
Name
FlyBase ID
RefSeq ID
Length (nt)
Assoc. CDS (aa)
FBtr0071653
5698
1377
FBtr0071654
6124
1426
Additional Transcript Data and Comments
Reported size (kB)

7.6, 7.1 (northern blot)

Comments
External Data
Crossreferences
Polypeptide Data
Annotated Polypeptides
Name
FlyBase ID
Predicted MW (kDa)
Length (aa)
Theoretical pI
UniProt
RefSeq ID
GenBank
FBpp0071570
153.6
1377
6.53
FBpp0071571
159.5
1426
7.03
Polypeptides with Identical Sequences

None of the polypeptides share 100% sequence identity.

Additional Polypeptide Data and Comments
Reported size (kDa)
Comments
External Data
Subunit Structure (UniProtKB)

Homodimer (PubMed:19718021, PubMed:20723758). Binding of the ligand spitz triggers homodimerization of the receptor however, it is able to form dimers, albeit weakly, in the absence of spitz (PubMed:19718021, PubMed:20723758). Interacts (when phosphorylated on tyrosine residues) with Vav (via SH2 domain) (PubMed:10781813). Interacts (when ubiquitinated) with Graf (PubMed:28993397). May interact (when phosphorylated) with EGFRAP (via SH2 domain) (PubMed:34411095).

(UniProt, P04412)
Post Translational Modification

Ubiquitination by Cbl in response to high spi, promotes its interaction with Graf and thus facilitates its GPI-enriched endocytic compartment (GEEC) mediated endocytosis and its subsequent degradation.

(UniProt, P04412)
Linkouts
Sequences Consistent with the Gene Model
Nucleotide / Polypeptide Records
 
Mapped Features

Click to get a list of regulatory features (enhancers, TFBS, etc.) and gene disruptions (point mutations, indels, etc.) within or overlapping Dmel\Egfr using the Feature Mapper tool.

External Data
Crossreferences
Eukaryotic Promoter Database - A collection of databases of experimentally validated promoters for selected model organisms.
Linkouts
Expression Data
Testis-specificity index

The testis specificity index was calculated from modENCODE tissue expression data by Vedelek et al., 2018 to indicate the degree of testis enrichment compared to other tissues. Scores range from -2.52 (underrepresented) to 5.2 (very high testis bias).

-1.26

Transcript Expression
in situ
Stage
Tissue/Position (including subcellular localization)
Reference
dorsal ectoderm anlage

Comment: anlage in statu nascendi

ectoderm anlage

Comment: anlage in statu nascendi

head mesoderm anlage

Comment: anlage in statu nascendi

mesectoderm anlage

Comment: anlage in statu nascendi

mesoderm anlage

Comment: anlage in statu nascendi

trunk mesoderm anlage

Comment: anlage in statu nascendi

ventral ectoderm anlage

Comment: anlage in statu nascendi

visual anlage in statu nascendi

Comment: reported as procephalic ectoderm anlage in statu nascendi

antennal anlage in statu nascendi

Comment: reported as procephalic ectoderm anlage in statu nascendi

dorsal head epidermis anlage in statu nascendi

Comment: reported as procephalic ectoderm anlage in statu nascendi

organism | ubiquitous

Comment: reference states 24 hr AEL

northern blot
Stage
Tissue/Position (including subcellular localization)
Reference
radioisotope in situ
Stage
Tissue/Position (including subcellular localization)
Reference
organism | ubiquitous

Comment: reference states 10-14 hr AEL

Additional Descriptive Data

Egfr transcript is expressed in a quadrant pattern in the wing pouch (excluded from the D/V and A/P compartment boundaries), and in the presumptive mesonotum and notum. In the haltere disc, Egfr is expressed in the prsumptive mesonotum, and in a small region surrounding the D/V compartment boundary.

Transcript is detected in a subset of the longitudinal glia in the ventral midline.

Egfr transcripts are distributed uniformly in the undifferentiated part of the eye-antennal disc from the antennal disc to in or slightly ahead of the morphogenetic furrow. They are also detected in the larval optic lobe in a pattern similar to the protein distribution.

Egfr transcripts are first observed in the late syncytial blastoderm embryo and increase substantially during cellularization. In gastrulating embryos, signal is higher in the ectoderm than in the endoderm or mesoderm and the strongest expression is seen in the cephalic furrow. During germ band extension, Egfr transcripts continue to be detected in the ectoderm and in the mesoderm. As the neuroblasts segregate, expression is missing in the neuroblast layer but is seen as two stripes along the germ band in the ectoderm and in the meso erm. In the later part of germ band extension, expression is detected in the stomodeum, the clypeo-labrum, and in the gnathal segments. Egfr is therefore found in all primordial tissues of the mouthparts and foregut. At stage 14, expression is observed in the region where the posterior spiracles and the telson will form. From stage 14 on, expression is observed in the ventral midline of the CNS. In stages 15 and 16, expression is observed along the entire periphery of the midgut. At stage 17, the most prominent regions of expression include the internal part of the proventriculus, the epit elium of the pharynx, and the fat body. In third instar larvae, expression is observed in imaginal discs. Expression is not evenly distributed among the discs or in a single disc. For example, in the eye disc, expression is abundant and uniform anterior to the morphogenetic furrow but posterior to the furrow is only found in the basal portion of the disc. Expression in the discs is observed in the epithelium but not in the adepithelium. Egfr is also expressed unevenly in developing ovaries and is detected in restricted regions of the CNS. Expression is observed in the inner and outer proli eration centers and in cells of the developing optic lamina. In addition, expression is found in a subset of polytene larval tissues including the valvular epithelium of the proventriculus and the fat body. Low levels of expression are seen in the salivary glands and in a subset of cells in the Malphigian tubules. The larval pattern of expression continues into prepupae. In early pupae, expression continues in the disc epithelia, the optic lamina, and fat body. Weak expression is also observed around each ovarian egg chamber. Later in the pupal period, expression declines in the midgut epith lium and is observed in the fore- and hindguts. Egfr expression in adults is mainly restricted to three types of tissues; imaginal fat body, valvular epithelium of the proventriculus, and the follicular epithelium of the ovary.

Egfr transcripts are observed in the periphery of cellular blastoderm embryos and persist at least until ventral furrow formation. In larvae, transcripts are observed in all imaginal discs and in subsets of cells within the cortex of the brain but not in the salivary glands. The expressing cells in the brain are thought to correspond to the proliferative centers. This pattern is consisten with Egfr expression preferentially in mitotically active cells. In ovaries, expression is observed in the vitellogenic follicle cells in young egg chambers. Follicle cells surrounding more mature oocytes no longer have higher levels of Egfr than the surrounding cells. Some transcript is also found in nurse cells and in the oocyte. In adults, some Egfr transcript is observed in males and females in tissues other than the ovary showing that some Egfr is expressed in nonproliferating cells in adults.

Egfr transcripts were found to be uniformly distributed in 10-14hr embryos and in 24hr embryos. In larvae, transcripts are uniformly distributed in the brain cortex, the anlagen of the ovaries and testes and in imaginal discs including the eye-antennal, wing, and genital discs. In adults, transcripts are localized in the cortex of the brain and in the thoracic and abdominal ganglia.

Egfr transcripts are detected at all stages of development tested. They are expressed at high levels in embryos and at reduced levels in larvae and pupae. In adults the 7.6kb transcript is much less abundant than the 7.1kb transcript.

Marker for
 
Subcellular Localization
CV Term
Polypeptide Expression
immunolocalization
Stage
Tissue/Position (including subcellular localization)
Reference
mass spectroscopy
Stage
Tissue/Position (including subcellular localization)
Reference
Additional Descriptive Data

In eye imaginal discs, the highest levels of Egfr protein are found anterior to the morphogenetic furrow. Just posterior to the furrow, the levels are sharply reduced in cells not recruited into the ommatidia but remain high in photoreceptor precursor cells. In the posterior of the eye disc the pattern is reversed. Levels are low in the ommatidia and highest in the surrounding undifferentiated cells that will become pigment and bristle nerve cells.

Egfr protein is detected in wholemount imaginal discs in a relatively uniform distribution. In eye discs, protein is observed in the furrow and anterior to the furrow but not posterior to the furrow. In sectioned discs, Egfr protein appears to be limited to the apical microvillar border of the eye disc epithelium anterior to and within the furrow. Staining is also observed in the presumptive larval optic lobes in the lateral and outer proliferation centers of the lamina. Finally, staining is seen along the midline of the ventral nerve cord.

Egfr protein is widely distributed throughout the cellular blastoderm embryo. It appears to be localized at the periphery of cells in the newly formed plasma membranes. During gastrulation, it is expressed in all ectodermal epithelial cells. In germ band extended embryos, it continues to be expressed in the ectoderm and is also expressed in the newly formed mesodermal cell layer. Intense staining in the head is also observed particularly in the mandibular bud, the procephalic lobe, and the clypeolabrum. In germ band retracted embryos, staining is observed in the epidermis at the tip of the clypeolabrum and in the epithelium of the terminal portion of the hindgut. Epidermal staining is also seen in the segmental grooves. Egfr staining is pronounced in germ band retracted embryos at the sites of somatic muscle attachments where it localizes particularly to the tendon cells at the ectodermal epithelial aspect of the apodemes. Most splanchnic mesodermal derivatives express Egfr. Staining is apparent in the fat body and in the visceral musculature. Finally, staining is pronounced in the ventral midline of the CNS.

Marker for
 
Subcellular Localization
CV Term
Evidence
References
inferred from direct assay
colocalizes_with cytoneme
inferred from direct assay
located_in plasma membrane
inferred from high throughput direct assay
inferred from direct assay
Expression Deduced from Reporters
Stage
Tissue/Position (including subcellular localization)
Reference
Reporter: P{Egfr-GAL4.R}
Stage
Tissue/Position (including subcellular localization)
Reference
High-Throughput Expression Data
Associated Tools

JBrowse - Visual display of RNA-Seq signals

View Dmel\Egfr in JBrowse
RNA-Seq by Region - Search RNA-Seq expression levels by exon or genomic region
Reference
See Gelbart and Emmert, 2013 for analysis details and data files for all genes.
Developmental Proteome: Life Cycle
Developmental Proteome: Embryogenesis
External Data and Images
Linkouts
BDGP expression data - Patterns of gene expression in Drosophila embryogenesis
DRscDB - A single-cell RNA-seq resource for data mining and data comparison across species
EMBL-EBI Single Cell Expression Atlas - Single cell expression across species
FlyAtlas - Adult expression by tissue, using Affymetrix Dros2 array
FlyAtlas2 - A Drosophila melanogaster expression atlas with RNA-Seq, miRNA-Seq and sex-specific data
Fly-FISH - A database of Drosophila embryo and larvae mRNA localization patterns
Flygut - An atlas of the Drosophila adult midgut
Images
FlyExpress - Embryonic expression images (BDGP data)
  • Stages(s) 4-6
  • Stages(s) 7-8
  • Stages(s) 9-10
  • Stages(s) 11-12
  • Stages(s) 13-16
Alleles, Insertions, Transgenic Constructs, and Aberrations
Classical and Insertion Alleles ( 134 )
For All Classical and Insertion Alleles Show
 
Other relevant insertions
Transgenic Constructs ( 57 )
For All Alleles Carried on Transgenic Constructs Show
Transgenic constructs containing/affecting coding region of Egfr
Transgenic constructs containing regulatory region of Egfr
Aberrations (Deficiencies and Duplications) ( 28 )
Inferred from experimentation ( 28 )
Gene partially duplicated in
Inferred from location ( 4 )
Variants
Variant Molecular Consequences
Alleles Representing Disease-Implicated Variants
Phenotypes
For more details about a specific phenotype click on the relevant allele symbol.
Lethality
Allele
Sterility
Allele
Other Phenotypes
Allele
Phenotype manifest in
Allele
adult cuticle & head capsule | dorsal, with Scer\GAL4c591
antenna & neuron | conditional ts, with Scer\GAL4hs.PB
axon & mechanosensory neuron & adult head, with Scer\GAL4unspecified
axon & ocellus sensory structure, with Scer\GAL4sca-537.4
border follicle cell & filopodium, with Scer\GAL4slbo.2.6
chordotonal organ precursor cell & ventral thoracic disc, with Scer\GAL4sca-109-68
cortical actin cytoskeleton & oocyte associated follicle cell, with Scer\GAL4slbo.2.6
embryonic trachea & cortical actin cytoskeleton, with Scer\GAL4btl.PS
head & macrochaeta | somatic clone
leg & macrochaeta | somatic clone
mesothoracic tarsal segment 1 & bract, with Scer\GAL4sca-537.4
mesothoracic tergum & macrochaeta | supernumerary, with Scer\GAL4ap-md544
microchaeta & abdominal sternite
microchaeta & abdominal tergite
neuron & eye disc | posterior | conditional ts (with Egfrf24)
neuron & eye disc | posterior | conditional ts (with Egfrtsla)
sensory neuron & axon & embryo, with Scer\GAL4repo
taste bristle & leg | ectopic, with Scer\GAL4Dll-md23
taste bristle & leg | ectopic, with Scer\GAL4sca-537.4
Orthologs
Human Orthologs (via DIOPT v9.1)
Species\Gene Symbol
Score
Best Score
Best Reverse Score
Alignment
Complementation?
Transgene?
Homo sapiens (Human) (74)
11 of 14
Yes
Yes
1  
11 of 14
Yes
Yes
11 of 14
Yes
Yes
1  
11 of 14
Yes
Yes
2 of 14
No
No
1 of 14
No
No
0  
1 of 14
No
No
2  
1 of 14
No
No
16  
1 of 14
No
Yes
1 of 14
No
No
1 of 14
No
No
4  
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1  
1 of 14
No
No
1 of 14
No
No
2  
1 of 14
No
No
1  
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1  
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
2  
1 of 14
No
No
1  
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1  
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
2  
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1  
1 of 14
No
Yes
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1  
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1  
1 of 14
No
No
1 of 14
No
No
1  
1 of 14
No
No
1  
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
Yes
1 of 14
No
No
Model Organism Orthologs (via DIOPT v9.1)
Species\Gene Symbol
Score
Best Score
Best Reverse Score
Alignment
Complementation?
Transgene?
Rattus norvegicus (Norway rat) (48)
10 of 14
Yes
Yes
10 of 14
Yes
Yes
10 of 14
Yes
Yes
10 of 14
Yes
Yes
1 of 14
No
No
1 of 14
No
No
1 of 14
No
Yes
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
Yes
1 of 14
No
No
Mus musculus (laboratory mouse) (56)
10 of 14
Yes
Yes
10 of 14
Yes
Yes
10 of 14
Yes
Yes
10 of 14
Yes
Yes
1 of 14
No
No
1 of 14
No
No
1 of 14
No
Yes
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
Yes
1 of 14
No
Yes
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1  
1 of 14
No
No
1  
1 of 14
No
Yes
1 of 14
No
No
Xenopus tropicalis (Western clawed frog) (41)
9 of 13
Yes
Yes
9 of 13
Yes
Yes
9 of 13
Yes
Yes
7 of 13
No
Yes
1 of 13
No
No
1 of 13
No
No
1 of 13
No
No
1 of 13
No
No
1 of 13
No
No
1 of 13
No
No
1 of 13
No
No
1 of 13
No
No
1 of 13
No
No
1 of 13
No
No
1 of 13
No
No
1 of 13
No
No
1 of 13
No
Yes
1 of 13
No
No
1 of 13
No
No
1 of 13
No
No
1 of 13
No
No
1 of 13
No
No
1 of 13
No
No
1 of 13
No
No
1 of 13
No
No
1 of 13
No
No
1 of 13
No
No
1 of 13
No
Yes
1 of 13
No
No
1 of 13
No
No
1 of 13
No
No
1 of 13
No
No
1 of 13
No
No
1 of 13
No
No
1 of 13
No
No
1 of 13
No
No
1 of 13
No
No
1 of 13
No
No
1 of 13
No
Yes
1 of 13
No
No
1 of 13
No
No
Danio rerio (Zebrafish) (62)
10 of 14
Yes
Yes
10 of 14
Yes
Yes
9 of 14
No
Yes
9 of 14
No
Yes
9 of 14
No
Yes
8 of 14
No
Yes
8 of 14
No
Yes
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
Yes
1 of 14
No
Yes
1 of 14
No
Yes
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
Yes
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
Yes
1 of 14
No
No
Caenorhabditis elegans (Nematode, roundworm) (63)
13 of 14
Yes
Yes
2 of 14
No
No
2 of 14
No
Yes
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
Yes
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
Yes
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
1 of 14
No
No
Anopheles gambiae (African malaria mosquito) (28)
12 of 12
Yes
Yes
1 of 12
No
No
Arabidopsis thaliana (thale-cress) (56)
1 of 13
Yes
No
1 of 13
Yes
Yes
1 of 13
Yes
Yes
1 of 13
Yes
Yes
1 of 13
Yes
No
1 of 13
Yes
Yes
1 of 13
Yes
No
1 of 13
Yes
No
1 of 13
Yes
No
1 of 13
Yes
No
1 of 13
Yes
No
1 of 13
Yes
Yes
1 of 13
Yes
Yes
1 of 13
Yes
No
1 of 13
Yes
Yes
1 of 13
Yes
No
1 of 13
Yes
Yes
1 of 13
Yes
No
1 of 13
Yes
No
1 of 13
Yes
No
1 of 13
Yes
No
1 of 13
Yes
No
1 of 13
Yes
No
1 of 13
Yes
No
1 of 13
Yes
No
1 of 13
Yes
No
1 of 13
Yes
Yes
1 of 13
Yes
No
1 of 13
Yes
Yes
1 of 13
Yes
Yes
1 of 13
Yes
No
1 of 13
Yes
Yes
1 of 13
Yes
Yes
1 of 13
Yes
No
1 of 13
Yes
No
1 of 13
Yes
No
1 of 13
Yes
No
1 of 13
Yes
No
1 of 13
Yes
No
1 of 13
Yes
No
1 of 13
Yes
No
1 of 13
Yes
No
1 of 13
Yes
No
1 of 13
Yes
No
1 of 13
Yes
No
1 of 13
Yes
No
1 of 13
Yes
Yes
1 of 13
Yes
Yes
1 of 13
Yes
Yes
1 of 13
Yes
Yes
1 of 13
Yes
No
1 of 13
Yes
No
1 of 13
Yes
No
1 of 13
Yes
No
1 of 13
Yes
Yes
1 of 13
Yes
Yes
Saccharomyces cerevisiae (Brewer's yeast) (0)
Schizosaccharomyces pombe (Fission yeast) (0)
Escherichia coli (enterobacterium) (0)
Other Organism Orthologs (via OrthoDB)
Data provided directly from OrthoDB:Egfr. Refer to their site for version information.
Paralogs
Paralogs (via DIOPT v9.1)
Drosophila melanogaster (Fruit fly) (40)
4 of 13
4 of 13
4 of 13
4 of 13
4 of 13
4 of 13
4 of 13
4 of 13
4 of 13
4 of 13
4 of 13
4 of 13
3 of 13
3 of 13
2 of 13
2 of 13
2 of 13
2 of 13
2 of 13
2 of 13
2 of 13
2 of 13
2 of 13
2 of 13
1 of 13
1 of 13
1 of 13
1 of 13
1 of 13
1 of 13
1 of 13
1 of 13
1 of 13
1 of 13
1 of 13
1 of 13
1 of 13
1 of 13
1 of 13
1 of 13
Human Disease Associations
FlyBase Human Disease Model Reports
Disease Ontology (DO) Annotations
Models Based on Experimental Evidence ( 6 )
Potential Models Based on Orthology ( 9 )
Modifiers Based on Experimental Evidence ( 16 )
Allele
Disease
Interaction
References
Disease Associations of Human Orthologs (via DIOPT v9.1 and OMIM)
Note that ortholog calls supported by only 1 or 2 algorithms (DIOPT score < 3) are not shown.
Functional Complementation Data
Functional complementation data is computed by FlyBase using a combination of the orthology data obtained from DIOPT and OrthoDB and the allele-level genetic interaction data curated from the literature.
Interactions
Summary of Physical Interactions
Interaction Browsers

Please see the Physical Interaction reports below for full details
RNA-protein
Physical Interaction
Assay
References
protein-protein
Physical Interaction
Assay
References
Summary of Genetic Interactions
Interaction Browsers

Please look at the allele data for full details of the genetic interactions
Starting gene(s)
Interaction type
Interacting gene(s)
Reference
suppressible
suppressible
Starting gene(s)
Interaction type
Interacting gene(s)
Reference
suppressible
suppressible
External Data
Subunit Structure (UniProtKB)
Homodimer (PubMed:19718021, PubMed:20723758). Binding of the ligand spitz triggers homodimerization of the receptor however, it is able to form dimers, albeit weakly, in the absence of spitz (PubMed:19718021, PubMed:20723758). Interacts (when phosphorylated on tyrosine residues) with Vav (via SH2 domain) (PubMed:10781813). Interacts (when ubiquitinated) with Graf (PubMed:28993397). May interact (when phosphorylated) with EGFRAP (via SH2 domain) (PubMed:34411095).
(UniProt, P04412 )
Linkouts
BioGRID - A database of protein and genetic interactions.
DroID - A comprehensive database of gene and protein interactions.
MIST (genetic) - An integrated Molecular Interaction Database
MIST (protein-protein) - An integrated Molecular Interaction Database
Pathways
Class of Gene
Genomic Location and Detailed Mapping Data
Chromosome (arm)
2R
Recombination map
2-95
Cytogenetic map
Sequence location
FlyBase Computed Cytological Location
Cytogenetic map
Evidence for location
57E9-57F1
Limits computationally determined from genome sequence between P{PZ}Egfr05351 and P{EP}CG10082EP436&P{EP}EP712EP712
Experimentally Determined Cytological Location
Cytogenetic map
Notes
References
57F1-57F2
(determined by in situ hybridisation)
57F1-57F1
(determined by in situ hybridisation)
57F-57F
(determined by in situ hybridisation)
Experimentally Determined Recombination Data
Left of (cM)
Right of (cM)
Notes
Stocks and Reagents
Stocks (69)
Genomic Clones (31)
cDNA Clones (43)
 

Please Note This section lists cDNAs and ESTs that fall within the genomic extent of the gene model, which may include cDNAs and ESTs of genes within introns, or of overlapping genes. Please see JBrowse for alignment of the cDNAs and ESTs to the gene model.

cDNA clones, fully sequenced
BDGP DGC clones
Other clones
Drosophila Genomics Resource Center cDNA clones

For each fully sequenced cDNA the DGRC maintains various forms of the cDNA (e.g tagged or untagged) in several different host vectors for subsequent cloning and expression in Drosophila and Drosophila cell lines.

cDNA Clones, End Sequenced (ESTs)
BDGP DGC clones
RNAi and Array Information
Linkouts
DRSC - Results frm RNAi screens
Antibody Information
Laboratory Generated Antibodies
Commercially Available Antibodies
 
Cell Line Information
Publicly Available Cell Lines
 
Other Stable Cell Lines
 
  • New stable cell line derived from S2-unspecified : Stable cell lines that express the full length spi protein (designated S2:spi ) or a truncated, secreted form of spi protein (designated S2:sspi ) were created. Stable cell lines that express Egfr were created and designated S2:DER1b and S2:DER2f . The S2:DER2f cell line is a constitutive Egfr-expressing cell line that was subsequently called D2F.

  • New stable cell line derived from S2-unspecified : Stable cell lines were generated starting from a S2+ line that stably expresses Egfr. This line was stably transformed with full length or mutant Ptp10D.

Other Comments

Identified as a candidate gene for hypoxia-specific selection (via an experimental evolution paradigm) that is also differentially expressed between control and hypoxia-adapted larvae.

Egfr is required to negatively regulate epidermal expression of dpp during dorsal closure.

Egfr signaling in the amnioserosa is required to repress zip expression in both the amnioserosa and the epidermis.

Egfr negatively regulates apoptosis in the amnioserosa.

Egfr signalling controls compartment size in embryos.

The jing and Egfr pathways are functionally related in the embryonic central nervous system midline and trachea.

Egfr signalling defines a protective function for ommatidial orientation in the eye.

A survey of association between 267 SNPs in almost 11kb of the Egfr gene and the degree of eye roughening due to a gain-of-function EgfrE1 allele crossed into 210 isogenic wild-type lines provides evidence that a handful of synonymous substitutions supply cryptic variation for photoreceptor determination.

Egfr signalling regulates ommatidial rotation and cell motility in the eye.

dsRNA made from templates generated with primers directed against this gene tested in RNAi screen for effects on Kc167 and S2R+ cell morphology.

Egfr in the peripodial membrane, mediates the role of the peripodial membrane in subdivision of the wing disc into presumptive wing and notum (mesothoracic tergum).

Photoreceptor differentiation in the eye disc requires intense Egfr signaling, whereas lower Egfr signaling levels are required at various times during eye development for cell cycle arrest, promotion of mitosis, and prevention of cell death.

Egfr is necessary for axon contact dependent inhibition of W dependent cell death of midline glial cells.

spi/Egfr signalling via the Ras/MAPK pathway mediates the induction of bract cell fate in the leg.

Egfr activation is required for progression from G2 to M phase in the second mitotic wave cells in the developing eye disc.

Egfr has a role in ommatidial spacing in the eye.

Excess Egfr signalling can overrule lateral inhibition in the proneural cluster and allow adjacent cells to become SMCs and sensory organs.

Egfr and N signalling pathways act antagonistically in mesothoracic bristle patterning. Proneural proteins trigger positive 'lateral co-operation' interactions mediated by Egfr and the Ras/Raf pathway among cells of the SMC cluster.

fus is required for full activity of the Egfr pathway in follicle cells.

Egfr signalling and net exert mutually antagonising activities during the specification of wing vein versus intervein fate. net is required to maintain intervein development by restricting Egfr signalling to the net-free vein regions of the wing disc.

Egfr activation in cyst cells may send a signal that prevents self-renewal of stem cell identity by the germ cell they enclose.

Egfr antagonises the wing-promoting function of dpp and allows recruitment of leg precursor cells from uncommitted ectodermal cells in the developing embryo.

The vn/Egfr pathway may be directly required for development of the notum by activating notum specifying genes and indirectly controlling wing outgrowth through regulation of ap.

Egfr signaling pathways are regulated by ebi.

rho-mediated hyperactivation of the Egfr/MAPK pathway is required for vein formation throughout late larval and early pupal development.

Eleven EMS induced alleles were identified in a screen for mutations affecting commissure formation in the CNS of the embryo.

Egfr interacts synergistically with wg to promote tergite and sternite identities in the adult abdomen, and Egfr and wg activities are opposed by dpp signalling which promotes pleural identity. wg and dpp compete directly by exerting opposite effects on cell fate. Within the tergite, the requirements of wg and Egfr function are complementary: wg is required medially, whereas Egfr is most important laterally.

Egfr has multiple functions in the specification of photoreceptor cell R8 and other photoreceptor cells and these may be distinguished by distinct thresholds of required Egfr activity.

Transcriptional regulation of ovo integrates inputs from the wg and Egfr pathways and control epidermis differentiation. The Egfr pathway promotes denticle formation by activating ovo expression.

Egfr signalling is inhibited by sty.

The femoral chordotonal organ arises from a cluster of sensory organ precursors (SOPs). N signalling is required to limit SOP commitment in the development of this cluster, but does not prevent multiple SOP formation because of the antagonistic action of Egfr signalling. Egfr signalling is required for clustering, promoting SOP commitment rather than proliferation or protection from cell death.

Activation of the Egfr/Ras85D/rl pathway specifically inhibits the proapoptotic activity of W.

Egfr signalling is required for the differentiation and maintenance of neural progenitors along the dorsal midline of the embryonic head.

Egfr activity is both necessary and sufficient for cartridge neuron assembly.

Egfr activation of Ras85D is required for cell survival in the embryo.

Egfr signalling promotes the 2o/3o pigment cell fate at the expense of programmed cell death in the interommatidial lattice.

Mutant eye phenotype suggests Egfr is involved in early aspects of ommatidial spacing, which presumably contributes to the overall roughness phenotype.

Immediately after the movement of the oocyte nucleus to the future dorsal pole a broad activation of the Egfr pathway takes place. As a result, all follicle cells, except the ventral-most rows, express Egfr-target genes. After completion of cell migration, transcription of rho in the dorsal-anterior follicle cells is achieved by activation of the Egfr pathway, in conjunction with signals that may emanate from the anterior, stretch follicle cells. Ectopic activation of rho in the stretch follicle cells can lead to activation of the Egfr pathway in the follicle cells covering the oocyte. Results suggest that rho is responsible for triggering the production or processing of a Egfr ligand that is expressed in the follicle cells. Genetic interaction studies suggest the S gene may participate in Egfr signalling in the ovary.

EGF domain swapping experiments of vn, spi and argos demonstrate that the EGF domain is the key determinant that gives Egfr inhibitors and activators their distinct properties.

The Egfr product promotes the formation, patterning and individual fate specification of early forming neuroblasts along the dorso-ventral axis of the embryo. Egfr signalling functions help specify the fate of medial neuroblasts and to promote neuroblast formation in the intermediate column. Egfr signalling is dispensable for the development of lateral column neuroblasts.

Egfr activity is essential for establishing the first ommatidial cell fate, the R8 photoreceptor neuron.

Egfr plays a critical role during endoderm induction. vn is the activating ligand of Egfr in the midgut. vn plays a permissive role in the induction of the endoderm by dpp and wg, which in turn up-regulate vn expression in the midgut mesoderm in two regions overlapping the dpp sources.

Egfr signalling plays an instructive role in CNS patterning and exerts differential effects on dorsoventral subpopulations of neuroblasts.

Sequential activation, amplification and local inhibition of the Egfr receptor forms an autoregulatory cascade that leads to the splitting of an initial single peak of signalling into two, patterning the dorsal egg.

Egfr is required to repress transcription of proneural genes and to promote neuroblast formation in the intermediate column of the neurectoderm.

Genetic combinations with mutants of nub cause additive phenotypes.

In the developing eye disc of Egfr mutant larvae the vast majority of cells fail to be recruited into preclusters and behave like nonrecruited cells, they undergo S phase and arrest in the following G2 phase. Only a minor fraction of the cells are released into mitoses to be recruited into developing ommatidia. Ectopic stg expression allows G2 arrested postfurrow cells to enter mitosis.

Shows no genetic interaction with sdk.

Egfr appears to be required for the initial determination of the correct midline glial cell number, as well as for further midline glia differentiation.

Phylogenetic analysis of the PTK family.

Signalling by the Egfr protein is critical for cell fate specification in the ventral cuticle of the Drosophila larva: this signalling pathway is required and apparently sufficient to specify row 1-4 denticles in the abdominal belts. To specify these denticles, signalling by the Egfr protein antagonises signalling by the wg protein in cells of the prospective row 1-4 zone.

The Egfr receptor pathway is activated by localized processing of the ligand spi in the tracheal placodes and is responsible for the capacity to form the dorsal trunk and visceral branch.

Expression of esg in the neuroectoderm is studied, the expression pattern prefigures that of the ASC genes. Egfr represses esg expression within the intermediate column.

Study of expression and function of different components of the N pathway in both the wing disc and pupal wings proposes that the establishment of vein thickness utilises a combination of mechanisms. A mechanisms includes repression of rho transcription by HLHmβ and maintenance of Dl expression by rho/Egfr activity.

The role of Egfr in chordotonal precursor formation is characterised.

Dr is regulated by the dorsoventral patterning genes Egfr and dpp in early embryos.

Egfr is required for the determination of all cells in the ommatidium, neuronal and nonneuronal. Egfr is even needed in R7. Egfr is sufficient to recruit all ommatidial cell types, including R7, implying that Egfr mediates a central recruitment mechanism in the eye.

The primary target genes of Egfr are pnt, vnd and Fas3, these are induced in different ectodermal domains. Secondary target genes oc, argos and trn are activated by pnt in response to Egfr signalling. The proper induction of these genes requires the concomitant inactivation of aop, mediated by Egfr signalling.

argos can be induced by Egfr activation in vivo and in Schneider cells.

The function of spi, rho and S appears to be non-autonomous; expression of the precursor only in the midline is sufficient for patterning the ventral ectoderm. Facilitating the expression of spi, rho and S is the only sim-dependent contribution of the midline to patterning the ventral ectoderm, since the mutant sim ectodermal defects can be overcome by expression of secreted spi in the ectoderm. These results suggest a mechanism for generating a graded distribution of secreted spi, which may subsequently give rise to graded activation of Egfr in the ectoderm.

Ectopic expression of Cf2 exacerbates heterozygous Egfr torpedo mutant phenotypes.

The distinction between pregland and preduct cells is made by the combination of two spatially separated negative regulatory steps: the Egfr signaling pathway represses fkh in the preduct cells and fkh represses duct specific genes in the pregland cells.

The Shc PTB domain (phosphotyrosine binding domain) possesses a binding specificity for tyrosine-phosphorylated peptides that is optimally suited for recognition of the activated Egfr receptor.

Molecular and genetic data suggest that vn is linked to the Egfr pathway and encodes a ligand for the Egfr product.

Double mutant analysis demonstrates a role for Ras85D gene product downstream of Egfr.

It is possible that rho plaques represent specialized structures defining sites of cell-cell contact at which Egfr signalling is particularly effective.

Egfr receptor is involved in the differentiation of a large subset of embryonic somatic muscles and their precursors. Temperature sensitive alleles of Egfr demonstrate the mesodermal function of the gene is required in the late extended germ band stage subsequent to its requirement in the ectoderm. spi group genes have a similar phenotype, loss of multiple mature muscles and their precursors.

In vitro fusion of the homologous extracellular domain of Egfr and Glt to the Nrt cytoplasmic domain can mediate aggregation of cells incubated with a soluble crude fraction containg Nrt ligand activity. The binding site for the Nrt ligand is localised within the extracellular domain. A stretch of 25 amino acids forms an alpha-helix located close to the pseudocatalytic site and is crucial for the adhesive function.

Mutations in components of the Egfr signalling pathway dominantly effect penetrance of the chic crossvein phenotype. Egfr is proposed to be an activator in longitudinal vein formation. There is a distinct signalling pathway activated by Egfr that interacts with Ras85D signal transduction cascade to induce crossvein formation in the wing that might be used for signalling processes elsewhere in the developing fly.

The generation of the anterior-posterior polarity in embryos involves a grk-Egfr signalling from the germ line to the soma.

Egfr is required for the induction of both posterior and dorsal follicle cell fates. Strong dominant enhancement of the Egfr phenotype by rl suggests that the MAPK pathway is involved in the induction of posterior follicle cell fate.

The spi product triggers the Egfr signaling cascade. Graded activation of the Egfr pathway may normally give rise to a repertoire of discrete cell fates in the ventral ectoderm and graded distribution of spi may be responsible for the graded activation. The rho and S products may act as modulators of Egfr signaling. Epistatic relationships suggest that rho and S may normally facilitate processing of the spi precursor.

argos represses the Egfr pathway in vivo and in vitro the argos protein can inhibit the activation of Egfr by spi. Thus the determination of cells by the Egfr pathway is regulated by a balance between extracellular activating and inhibiting signals.

Mutations can act as dominant modifiers of the activated N eye phenotype (FBrf0064452).

Mutant combinations of phl and Egfr demonstrates that phl acts downstream of Egfr.

Activation of the Egfr pathway during oogenesis is not sufficient to specify dorsal fate when activated ectopically.

Molecular analysis of mutant alleles reveals an intriguing correlation between molecular lesions and mutant phenotypes. Alleles that specifically affect specific processes encode receptors with altered extracellular domains. Alleles that fully or partially complement a wide range of embryonic and postembryonic phenotypes encode receptors with altered intracellular domains. These findings suggest that the Egfr protein may be activated by tissue specific ligands, that the Egfr receptor tyrosine kinase may phosphorylate multiple substrates, that signal transduction by Egfr requires the physical association of substrates and that the extracellular domain of the Egfr protein may play an essential role in mediating receptor-receptor interactions.

The grk-Egfr signalling process plays an instructive role in oogenesis, inducing dorsal cell fates in the follicle cell epithelium and controlling the production of maternal compnents that will direct the embryonic dorsoventral pattern.

Levels of Egfr mRNA are strongly down-regulated in epidermal cells likely to have undergone high levels of Egfr medieted signaling.

Egfr requirement for Malpighian tubule development is during the period of cell division.

Mutations in Egfr affect the development of the Malpighian tubules, final cell number is reduced. The two pairs of tubules are affected to a different extent.

Displays epistatic interactions with sqd alleles.

Observations of mutants support the proposal that axon fascicles can make at least some pathfinding decisions independently of their neighbours.

The alternate 5' end of Egfr reported by Schejter et al. (Cell 46: 1091--1101) is a cloning artefact and is actually from 14-3-3ζ of Swanson and Ganguly (Gene 113: 183--190).

Molecular analysis of grk suggests that it is the Egfr ligand functioning in the female germline in dorsoventral patterning.

Egfr gene product is essential for determining the identity of cells within the ventral ectoderm.

Double mutant analysis indicates that ve acts upstream of Toll in dorsal-ventral axis formation, and the action of ve requires the grk-Egfr signaling pathway.

rho gene product acts synergistically with Egfr signalling components.

Egfr is required for normal cell proliferation in all imaginal discs. Egfr- cells in the eye disc are unable to differentiate as photoreceptor cells. Clonal analysis of cells carrying both loss of function and gain of function Egfr mutations indicates that, in either case, cells are more likely to differentiate as photoreceptors if they are in contact with cells of lower Egfr activities.

Mutations affect eye morphology.

Double mutant brn;Egfr mothers lay strongly ventralised eggs.

Basic protein structure, comparison of phenotypes and spatial and temporal expression patterns suggest that spi encodes a ligand that functionally interacts with the products of rho and possibly Egfr.

Egfr protein expression in third instar larval imaginal discs has been determined.

Egfr RNA expression during development has been studied.

The phenotype of heteroallelic combinations of a large number of Egfr mutations has been studied.

The Sos gene product is in the Egfr receptor tyrosine kinase pathway but the interaction of Sos with Egfr is limited to the developing eye.

Mutations at the Egfr locus cause defects in midoogenesis.

Zygotically active locus involved in the terminal developmental program in the embryo.

Fas3, mys, disco, zip, l(2)gl, N and Egfr mutants show an additive phenotype in combination with Fas1TE89Da.

The Egfr protein is glycosylated and is located in the plasma membrane.

The expression of Egfr protein during embryonic development has been characterised. Analysis of Egfr mutant embryos shows that the CNS develops normally, and that the severe CNS phenotype ultimately observed is due to secondary collapse of the CNS.

Egfr is required for oogenesis, embryogenesis, pupal viability and for the growth of the eye-antennal, wing and haltere imaginal discs. Egfr is necessary for proper wing venation, development of the arista, legs and female genital disc and mutations alter the distribution of macrochaetae.

Mutation in Egfr are epistatic to the dorsalizing action of capu and spir in the dorsoventral axis.

Germ line mosaic analysis demonstrates that the Egfr gene product is required in the somatic cells for chorion patterning and dorsoventral patterning of embryonic cells.

Egfr has been isolated and characterised, the protein has three functional domains similar to the human EGF receptor.

In situ hybridisation has revealed a unique growth factor that binds both insulin and epidermal growth factor (EGF) and is antigenically related to the EGF receptor of mammals.

Encodes the Drosophila homolog of epidermal growth factor receptor protein. Mutations with three different phenotypes and described under three different names shown to be alleles of Egfr. Elp (Ellipse) is a dominant eye shape and texture mutant; flb (faint little ball) is an embryonic lethal causing dorsalized embryos, and top (torpedo) is a maternal-effect lethal causing ventralized embryos. Ellipse alleles are dominant (hypermorphic) mutations of Egfr. EgfrE1 in heterozygous combination with a deficiency or null mutation for Egfr is normal in phenotype. Eyes of EgfrE1/+ heterozygotes rough and more oval than wild type; also display a slight disturbance of the wing-vein pattern. Homozygotes have smaller eyes with many fewer ommatidia and some regions lack them entirely; those ommatidia that are formed contain the normal number and arrangement of cells; the regions without ommatidia contain cells that resemble pigment cells and mechanosensory bristles; only about one tenth the normal number of preommatidial cell clusters differentiate behind the morphogenetic furrow. faint little ball alleles (Egfrf) are recessive embryonic lethal alleles of Egfr that lack a maternal effect (as shown by pole cell transplantation). Embryos form a ball of dorsal hypoderm with the internal organs extruded anteriorly. Ventral cuticle absent or strongly reduced. First visible in extended-germ-band stage. Cells at the anterior and posterior ends of the embryo form clumps and slough off; very few head and gnathal cells remain. Substantial ectodermal cell death observed; germ band retraction fails to take place. Ultimately, cuticle formation produces mostly dorsal and lateral cuticular elements with but a narrow strip of denticles midventrally. Hypomorphic alleles initiate but do not complete germ-band retraction; they show intermediate phenotypes with wider denticle bands and in weak alleles some head and telson structures are formed as well. torpedo alleles (Egfrt) are maternal effect lethals. Maternal-effect lethal. Homozygous females lay eggs that are long and pointed at both ends. Such eggs often have only one fused dorsal appendage; also there is an increase in the number of follicle cells that give rise to the main body of the chorion at the expense of those ordinarily contributing to the operculum and dorsal appendages. "Egfrt" alleles are completely recessive and fully penetrant in homozygous females; the embryos never hatch. Homozygous and hemizygous adult flies exhibit incomplete fourth veins, absence of the anterior crossvein, rough eyes, loss of ocelli and ocellar bristles and the loss of sensory bristles from the thorax. Changes in the embryonic pattern become visible at the beginning of gastrulation. Around the circumference of the embryo, 40% of the cells invaginate on the ventral side and form mesoderm; these cells become organized into two ventral furrows which are lost in later stages and a mass of mesodermal cells fills the ventral half of the embryo. The only cuticle structure differentiated is a strip of dorsal hypoderm flanked by bands of ventral setae; lateral and ventral sides are made up of mesoderm. The head is reduced but filzkorper and spiracles are visible posteriorly. Experiments with germ-line mosaics produced by pole cell transplantation indicate that the mutant gives rise to ventralized eggs and embryos by interfering with processes taking place in somatic cells rather than germinal tissue. The mutant phenotype was only produced in mosaics in which wild-type germ cells were surrounded by Egfrt follicle cells and not by the reverse cell arrangement. Egfrt blocks dorsalization caused by fs(1)K10, but not that produced by dl females. In situ hybridization with transcript-specific probes reveals uniform distribution of transcript during embryogenesis; in larvae, hybridization confined to mitotic tissues and not seen in cells with polytene chromosomes (Kammermeyer and Wadsworth, 1987). Transcript concentrated in cells of the central nervous system and gonial cells in adults.

Relationship to Other Genes
Source for database merge of

Source for merge of: Egfr l(2)05351

Additional comments

Identified by PCR fragment; relationship to other protein tyrosine kinase genes not known.

Identified by PCR fragment; relationship to other protein tyrosine kinase genes not known. Price, Clifford and Schupbach (1989) subsumed the embryonic lethal alleles (flb) under the symbol for the maternal-effect-lethal alleles (top). Lindsley and Zimm (1992) further consolidated both along with the dominant visible alleles (Elp) under the symbol Egfr as "Egfrf", "Egfrt" and "EgfrE" alleles respectively.

Nomenclature History
Source for database identify of
Nomenclature comments
Etymology
Synonyms and Secondary IDs (78)
Reported As
Symbol Synonym
C-erb
DER
(Tomlinson et al., 2019, Chabu et al., 2017, Mavromatakis and Tomlinson, 2017, Chen et al., 2016, Auer et al., 2015, Auer et al., 2015, Mbodj et al., 2013, Mora et al., 2013, Cordero et al., 2012, Egoz-Matia et al., 2011, Friedman et al., 2011, Olson et al., 2011, Stec and Zeidler, 2011, Tomlinson et al., 2011, Zhang et al., 2011, Hamaratoglu et al., 2009, Mallik and Lakhotia, 2009, del Alamo and Mlodzik, 2008, Melani et al., 2008, Moon et al., 2007, Prasad and Montell, 2007, Wang et al., 2007, Chanut-Delalande et al., 2006, Friedman and Perrimon, 2006, Gallagher and Knoblich, 2006, Moon et al., 2006, Srahna et al., 2006, Wang et al., 2006, Dutta et al., 2005, Jekely et al., 2005, Magie and Parkhurst, 2005, Müller et al., 2005, Ramos and Robert, 2005, Sen et al., 2005, Delon and Payre, 2004, Hidalgo and Griffiths, 2004, Klein et al., 2004, MacDougall et al., 2004, Matsuda et al., 2003, Rintelen et al., 2003, Shirai et al., 2003, Beck and Fainzilber, 2002, Carmena et al., 2002, Curtiss et al., 2002, Hatfield et al., 2002, Liu and Rohrschneider, 2002, Morey et al., 2002, Nakagoshi et al., 2002, Rebay, 2002, Stathopoulos and Levine, 2002, Bogdan and Klämbt, 2001, Duchek and Rorth, 2001, Fiorini et al., 2001, Morey et al., 2001, Rohrbaugh et al., 2001, Roth, 2001, Vanden Broeck et al., 2001, Wakabayashi-Ito et al., 2001, Wang et al., 2001, Williams and Nagy, 2001, Zhao and Skeath, 2001, Bang and Kintner, 2000, Baonza et al., 2000, Carthew et al., 2000, Dequier et al., 2000, Garcia-Alonso et al., 2000, Ghazi and VijayRaghavan, 2000, Gonzalez-Gaitan and Jackle, 2000, Hayashi and Saigo, 2000, Jin et al., 2000, Klambt, 2000, Kumar and Moses, 2000, Martin-Blanco et al., 2000, Raabe, 2000, Reich et al., 2000, Roche, 2000, Simon, 2000, Staudt et al., 2000, Thackeray et al., 2000, Vinos and Freeman, 2000, Xu et al., 2000, Zhao and Skeath, 2000, Zhao et al., 2000, Adachi-Yamada et al., 1999, Amin et al., 1999, Chen and Chien, 1999, den Hertog, 1999, Duronio, 1999, Frasch, 1999, Granderath and Klambt, 1999, Greenwood and Struhl, 1999, Kodjabachian, 1999, Kopp et al., 1999, Lanoue and Jacobs, 1999, Martin-Blanco et al., 1999, Moghal and Sternberg, 1999, Palmer et al., 1999, Payre et al., 1999, Payre et al., 1999, Schulz and Gajewski, 1999, Skeath, 1999, Staudt et al., 1999, Stronach and Perrimon, 1999, Wessells et al., 1999, Anderson, 1998, Anonymous, 1998, Buff et al., 1998, Carmena et al., 1998, Chen et al., 1998, Crews, 1998, Hayashi et al., 1998, Hsu et al., 1998, Meier and Evan, 1998, Miller and Cagan, 1998, Sapir et al., 1998, Schnepp et al., 1998, Schnepp et al., 1998, Shilo et al., 1998, Skeath, 1998, Skeath, 1998, Spencer et al., 1998, Udolph et al., 1998, Yagi et al., 1998, Yang and Irvine, 1998, Yarnitzky et al., 1998, Bryant, 1997, Buff et al., 1997, Donaldson et al., 1997, Dong and Jacobs, 1997, Freeman, 1997, Freeman et al., 1997, Gabay et al., 1997, Goldstein and Freeman, 1997, Golembo et al., 1997, Grumbling et al., 1997, Hafen, 1997, Jacobs et al., 1997, Jaffe et al., 1997, Klambt, 1997, Li and Perrimon, 1997, Neumann and Cohen, 1997, O'Keefe et al., 1997, Okabe and Okano, 1997, Okabe and Okano, 1997, Okabe and Okano, 1997, Scholz et al., 1997, Scholz et al., 1997, Shilo et al., 1997, Simcox, 1997, Skeath, 1997, Spencer and Cagan, 1997, Stemerdink and Jacobs, 1997, Szuts et al., 1997, Wappner et al., 1997, Yagi and Hayashi, 1997, zur Lage and Jarman, 1997, zur Lage et al., 1997, Bonfini et al., 1996, Duffy and Perrimon, 1996, Freeman, 1996, Gabay et al., 1996, Goldman-Levi et al., 1996, Golembo et al., 1996, Golembo et al., 1996, Golembo et al., 1996, Huang and Fischer-Vize, 1996, Johnson and Perkins, 1996, Klämbt et al., 1996, Knust, 1996, Kuo et al., 1996, Li et al., 1996, MacDougall and Waterfield, 1996, Perkins et al., 1996, Schnepp et al., 1996, van der Geer et al., 1996, Gonzalez-Reyes et al., 1995, Munn and Steward, 1995, Schweitzer et al., 1995, Brunner et al., 1994, Kylsten, 1994, Perrimon, 1994, Reichman-Fried et al., 1994, Thomas and Zipursky, 1994, Wilson, 1994, Baumann and Skaer, 1993, Cagan, 1993, Dickson and Hafen, 1993, Doyle and Bishop, 1993, Mardon et al., 1993, Noll et al., 1993, Pawson, 1993, Pawson et al., 1993, Raabe et al., 1993, Raz and Shilo, 1993, Steward and Govind, 1993, Hoffmann et al., 1992, Rutledge et al., 1992, Saint and Wigley, 1992, Zak and Shilo, 1992, Katzen et al., 1991, Madhavan et al., 1991, Raz et al., 1991, Rubin, 1991, Shilo and Raz, 1991, Shishido et al., 1991, Xu and Rubin, 1991, Katzen, 1990, Pawson and Bernstein, 1990, Wides et al., 1990, Zak and Shilo, 1990, Zak et al., 1990, Schejter and Shilo, 1989)
DER/top
EGFR
(Alvarez and Papagiannouli, 2025, Badmos and Cagan, 2025, Castello-Pons et al., 2025, Clarke et al., 2025, Diaz et al., 2025, Dong et al., 2025, Giansanti et al., 2025, Ho et al., 2025, Li et al., 2025, Park et al., 2025, Scopelliti et al., 2025, Serebrovska et al., 2025, Tuan et al., 2025, Wang et al., 2025, Zhang et al., 2025, Joy et al., 2024, Kim et al., 2024, Megaly et al., 2024, Roach and Lenhart, 2024, Sharmin et al., 2024, Shweta et al., 2024, Wang et al., 2024, Wang et al., 2024, Yuswan et al., 2024, Zeng et al., 2024, Baldenius et al., 2023, Corty and Coutinho-Budd, 2023, Khan et al., 2023, Sharpe et al., 2023, Smits et al., 2023, Villars et al., 2023, Yan et al., 2023, Adashev et al., 2022, Almeida Machado Costa et al., 2022, Beaven and Denholm, 2022, Campanale et al., 2022, Chopra et al., 2022, Ding et al., 2022, Enomoto and Igaki, 2022, Inaki et al., 2022, Jarabo et al., 2022, Liu et al., 2022, Milas and Telley, 2022, Neophytou and Pitsouli, 2022, Papagiannouli, 2022, Thangadurai et al., 2022, Valencia-Expósito et al., 2022, Xiao, 2022, Xiu et al., 2022, Xu et al., 2022, Yasugi and Sato, 2022, Zhang and Edgar, 2022, Al Hayek et al., 2021, Bailey et al., 2021, Bischoff and Bogdan, 2021, Boumard and Bardin, 2021, Charlton-Perkins et al., 2021, Finger et al., 2021, Gong et al., 2021, Harnish et al., 2021, Johnson, 2021, Lam Wong and Verheyen, 2021, Lim et al., 2021, Meschi and Delanoue, 2021, Millet-Boureima et al., 2021, Morin-Poulard et al., 2021, Rajasekaran et al., 2021, Sênos Demarco and Jones, 2021, Shahzad et al., 2021, Sinenko et al., 2021, Soler Beatty et al., 2021, Tiwari and Mandal, 2021, Wang, 2021, Yamamura et al., 2021, Zhao et al., 2021, Adrain and Cavadas, 2020, Barredo et al., 2020, Chen and Desplan, 2020, Dai et al., 2020, Fujisawa et al., 2020, Gerlach and Herranz, 2020, Gou et al., 2020, Gutiérrez-Martínez et al., 2020, Hayashi and Ogura, 2020, Hou et al., 2020, Jasper, 2020, Jin et al., 2020, Kanda and Igaki, 2020, Liu et al., 2020, Luo et al., 2020, Manière et al., 2020, Merkle et al., 2020, Mira and Morante, 2020, Petruccelli et al., 2020, Revaitis et al., 2020, Sato and Yasugi, 2020, Schloop et al., 2020, Sheng and Du, 2020, Texada et al., 2020, Washington et al., 2020, Yan et al., 2020, Chen et al., 2019, Gerlach et al., 2019, Gervais et al., 2019, Kim and Choi, 2019, Mao et al., 2019, Suisse and Treisman, 2019, Wittes and Schüpbach, 2019, Zhu et al., 2019, Baranski et al., 2018, Campbell et al., 2018, Crossman et al., 2018, Drelon et al., 2018, Enomoto et al., 2018, Molnar et al., 2018, Perochon et al., 2018, Powers and Srivastava, 2018, Ruiz-Losada et al., 2018, Sriskanthadevan-Pirahas et al., 2018, Wang et al., 2018, Ahmad, 2017, Liu and Jin, 2017, Liu and Jin, 2017, Liu et al., 2017, Lusk et al., 2017, Park et al., 2017, Pascual et al., 2017, Requena et al., 2017, Song et al., 2017, Strilbytska et al., 2017, Wang et al., 2017, Willoughby et al., 2017, Xiang et al., 2017, Xu et al., 2017, Yamamoto et al., 2017, Agnihotri et al., 2016, Cai et al., 2016, Chen et al., 2016, Freeman, 2016, Jussen et al., 2016, Klebanow et al., 2016, Lovick et al., 2016, Padash Barmchi et al., 2016, Sheng et al., 2016, Wang et al., 2016, Yadav et al., 2016, Bieli et al., 2015, Chen et al., 2015, Dorn and Dorn, 2015, Enomoto et al., 2015, Enomoto et al., 2015, Gilboa, 2015, Hall and Verheyen, 2015, Hernández et al., 2015, Kallsen et al., 2015, Liu et al., 2015, Nie et al., 2015, Pasco et al., 2015, Peláez et al., 2015, Reitman et al., 2015, Sansone et al., 2015, Yu et al., 2015, Yurgel et al., 2015, Zhai et al., 2015, Housden et al., 2014, Huang et al., 2014, Lee et al., 2014, Palsson et al., 2014, Park et al., 2014, Pichaud, 2014, Rowshanravan et al., 2014, You et al., 2014, Zhang et al., 2014, Zschätzsch et al., 2014, Ayyaz and Jasper, 2013, Caviglia and Luschnig, 2013, Fernández-Espartero et al., 2013, Ferrandon, 2013, Fregoso Lomas et al., 2013, Gonzalez, 2013, Groth et al., 2013, Hombría and Serras, 2013, Hudson et al., 2013, Mishra et al., 2013, Muha and Müller, 2013, Ozkan et al., 2013, Rahn et al., 2013, Ren et al., 2013, Sasamura et al., 2013, Sato et al., 2013, Takashima et al., 2013, Västermark et al., 2013, Wang et al., 2013, Webber et al., 2013, Wong et al., 2013, Yin et al., 2013, Yu et al., 2013, Foronda et al., 2012, Fuchs et al., 2012, Haskel-Ittah et al., 2012, Herranz et al., 2012, Herranz et al., 2012, Inaki et al., 2012, Legent et al., 2012, Mitra et al., 2012, Ruiz et al., 2012, Wang et al., 2012, Whitworth et al., 2012, Yue et al., 2012, Yu et al., 2012, Zoller and Schulz, 2012, Bangi et al., 2011, Eliazer and Buszczak, 2011, Friedman et al., 2011, Geiger et al., 2011, Grigorian et al., 2011, Hadjieconomou et al., 2011, Helman et al., 2011, Hidalgo et al., 2011, Kawamori and Yamaguchi, 2011, Lee et al., 2011, Makhijani et al., 2011, Molnar et al., 2011, Moses et al., 2011, Poukkula et al., 2011, Read, 2011, Roy et al., 2011, Roy et al., 2011, Salamanca et al., 2011, Stec and Zeidler, 2011, Takemura and Adachi-Yamada, 2011, Tjota et al., 2011, Wang and Pai, 2011, Wojcinski et al., 2011, Alvarado et al., 2010, Assaker et al., 2010, Buchon et al., 2010, Chanut-Delalande et al., 2010, de Celis and Molnar, 2010, Figeac et al., 2010, Guenin et al., 2010, Herr et al., 2010, Kim et al., 2010, Wang et al., 2010, Wang et al., 2010, Yogev et al., 2010, Yu et al., 2010, Birkholz et al., 2009, Cruz et al., 2009, Hurlbut et al., 2009, Jang et al., 2009, Lembong et al., 2009, Li et al., 2009, Mao and Freeman, 2009, Maybeck and Röper, 2009, Nagaraj and Banerjee, 2009, Nicholson et al., 2009, Ni et al., 2009, Pizette et al., 2009, Read et al., 2009, Steele et al., 2009, Vaccari et al., 2009, Witte et al., 2009, Aritakula and Ramasamy, 2008, Baudot et al., 2008, Chang et al., 2008, Cinnamon et al., 2008, Cobreros et al., 2008, Duong et al., 2008, Gonzalez et al., 2008, Haberman et al., 2008, Iyadurai et al., 2008, Kandachar et al., 2008, Legent et al., 2008, Miura et al., 2008, Ni et al., 2008, Patel and Jacobs, 2008, Read and Thomas, 2008, Simmons and Spencer, 2008, Sprecher and Desplan, 2008, Steinhauer and Treisman, 2008, Swanson and Barolo, 2008, Vielmas et al., 2008, Wang et al., 2008, Wang et al., 2008, Yakoby et al., 2008, Yogev et al., 2008, Zartman et al., 2008, Zheng and Carthew, 2008, Bernardi et al., 2007, Bianco et al., 2007, Bianco et al., 2007, Bruinsma et al., 2007, Bulanin and Orenic, 2007, Chang et al., 2007, Cinnamon et al., 2007, Copeland et al., 2007, de Velasco et al., 2007, Doroquez et al., 2007, Foltenyi et al., 2007, Hashimoto and Yamaguchi, 2007, Jaramillo et al., 2007, Kim et al., 2007, Lim et al., 2007, Luo et al., 2007, Montrasio et al., 2007, Nagaraj and Banerjee, 2007, Prasad and Montell, 2007, Reeves and Shvartsman, 2007, Robertson et al., 2007, Sprecher et al., 2007, Yogev et al., 2007, Yoneda et al., 2007, Charroux et al., 2006, Gilboa and Lehmann, 2006, Goentoro et al., 2006, Hagedorn et al., 2006, Jaramillo et al., 2006, Liu et al., 2006, Maitra et al., 2006, Maitra et al., 2006, Mason et al., 2006, McDonald et al., 2006, Mezey et al., 2006, Miura et al., 2006, Molnar et al., 2006, Montell, 2006, Moon et al., 2006, Parker, 2006, Paul et al., 2006, Philippakis et al., 2006, Poulton and Deng, 2006, Reeves et al., 2006, Schulz et al., 2006, Urban, 2006, Wang et al., 2006, Apitz et al., 2005, Burnette et al., 2005, Chen et al., 2005, Chotard et al., 2005, de Velasco and Hartenstein, 2005, Galindo et al., 2005, Go, 2005, Jekely et al., 2005, Korochkina et al., 2005, Li and Carthew, 2005, Lievens et al., 2005, Maitra et al., 2005, Papadia et al., 2005, Reeves et al., 2005, Ruiz-Gomez et al., 2005, Shilo, 2005, Sundaram, 2005, Walters et al., 2005, Yakoby et al., 2005, Yamashita et al., 2005, Layalle et al., 2004, Patel et al., 2004, Starz-Gaiano and Montell, 2004, Treisman, 2004, Voas and Rebay, 2004, Wheeler et al., 2004, de Celis and Diaz Benjumea, 2003, Frankfort and Mardon, 2003, Gonzalez-Gaitan, 2003, Jekely and Rorth, 2003, McGovern et al., 2003, Palsson et al., 2003, Pribyl et al., 2003, Skeath and Thor, 2003, Gorski and Marra, 2002, Hidalgo, 2002, Richardson and Kumar, 2002, Rorth, 2002, Baker et al., 2001, Campuzano, 2001, Gim et al., 2001, Kockel et al., 2001, Yang and Baker, 2001, Garcia-Alonso et al., 2000, Wang et al., 2000, Dominguez et al., 1998, Howes et al., 1998, Cooperstock and Lipshitz, 1997, Dominguez et al., 1997, Wappner et al., 1997, Livneh, 1994.10.30, Schejter, 1994.10.27, Schejter, 1988.6.15)
Egfr
(Shi et al., 2026, Bischoff et al., 2025, Joly et al., 2025, Klimkowski Arango and Morgante, 2025, Lee et al., 2025, Li et al., 2025, Qin et al., 2025, Ramirez Moreno et al., 2025, Berg et al., 2024, Collins et al., 2024, Eslahi et al., 2024, Garcia-Alonso, 2024, Goins et al., 2024, Ko et al., 2024, Perlegos et al., 2024, Turingan et al., 2024, Vialat et al., 2024, Wang et al., 2024, Zambrano-Tipan et al., 2024, Attrill, 2023, Corthals et al., 2023, Kim et al., 2023, Li and Karpac, 2023, Pan et al., 2023, Prasad et al., 2023, Socha et al., 2023, Taniguchi and Igaki, 2023, Jiang et al., 2022, Joseph et al., 2022, Perlegos et al., 2022, Yuen et al., 2022, Zhang et al., 2022, Zhao et al., 2022, Bilder et al., 2021, Bonfini et al., 2021, Brás et al., 2021, Buddika et al., 2021, Cheng et al., 2021, DeAngelis et al., 2021, Everetts et al., 2021, Fabian et al., 2021, Johnson and Leatherman, 2021, Liang et al., 2021, Ostalé et al., 2021, Pan and O'Connor, 2021, Park et al., 2021, Proske et al., 2021, Pryszlak et al., 2021, Resnik-Docampo et al., 2021, Spierer et al., 2021, Ahmed et al., 2020, Cruz et al., 2020, Denton et al., 2020, Du et al., 2020, Ghosh et al., 2020, Jeon et al., 2020, Kim et al., 2020, Li et al., 2020, Nakamura et al., 2020, Nye et al., 2020, Pan et al., 2020, Rambur et al., 2020, Sênos Demarco and Jones, 2020, Sênos Demarco et al., 2020, van Soldt and Cardoso, 2020, Zhang et al., 2020, Zhe et al., 2020, Ben-Zvi and Volk, 2019, Bossen et al., 2019, Chen and Read, 2019, Chen et al., 2019, Coelho and Moreno, 2019, Everman et al., 2019, Han, 2019.5.8, Highfill et al., 2019, Huichalaf et al., 2019, Khan et al., 2019, La Marca et al., 2019, Mele and Johnson, 2019, Meltzer et al., 2019, Moreno et al., 2019, Mundorf et al., 2019, Nelson et al., 2019, Ohsawa, 2019, Pitchers et al., 2019, Schumacher, 2019, Schüpbach, 2019, Sênos Demarco and Jones, 2019, Stamm et al., 2019, Tudrej et al., 2019, Xu et al., 2019, Zhang et al., 2019, Bala Tannan et al., 2018, Courgeon et al., 2018, Das et al., 2018, Duan et al., 2018, Eichenlaub et al., 2018, Hassan et al., 2018, Kittelmann et al., 2018, Kumar, 2018, Lee et al., 2018, Levings and Nakato, 2018, Li et al., 2018, Liu et al., 2018, Molnar et al., 2018, Mortensen et al., 2018, Newcomb et al., 2018, Schwarz et al., 2018, Stephano et al., 2018, Stuelten et al., 2018, Tseng et al., 2018, Zhang et al., 2018, Baker, 2017, Banisch et al., 2017, Carrell et al., 2017, Chabu et al., 2017, Feng et al., 2017, Fochler et al., 2017, Kim et al., 2017, Louradour et al., 2017, Martin et al., 2017, Osterfield et al., 2017, Park et al., 2017, Rohde et al., 2017, Takemura and Nakato, 2017, Tan et al., 2017, Transgenic RNAi Project members, 2017-, Valdivia et al., 2017, Yoon et al., 2017, Ashton-Beaucage et al., 2016, Gene Disruption Project members, 2016-, Iyer et al., 2016, Jha et al., 2016, Jiang et al., 2016, Li et al., 2016, Malartre, 2016, Petruccelli et al., 2016, Quan et al., 2016, Xin et al., 2016, Auer et al., 2015, Duff et al., 2015, Garlapow et al., 2015, Gene Disruption Project members, 2015-, Gonzalez et al., 2015, Grotewiel and Bettinger, 2015, Jin et al., 2015, Kim et al., 2015, Li et al., 2015, Li et al., 2015, Lim et al., 2015, Liu et al., 2015, Patel et al., 2015, Sîrbu et al., 2015, Ugrankar et al., 2015, Austin et al., 2014, Baril et al., 2014, Cai et al., 2014, Gonzalez et al., 2014, Guo et al., 2014, Herranz et al., 2014, Iordanou et al., 2014, Matsuoka et al., 2014, Salazar-Jaramillo et al., 2014, Tchankouo-Nguetcheu et al., 2014, Tipping and Perrimon, 2014, Truscott et al., 2014, Buchon et al., 2013, Chen et al., 2013, Curtis et al., 2013, Jin et al., 2013, Kondo and Hayashi, 2013, Kwon et al., 2013, Li et al., 2013, Lim et al., 2013, Lin et al., 2013, Molnar and de Celis, 2013, Muñoz-Soriano et al., 2013, Ozkan et al., 2013, Ozkan et al., 2013, Park et al., 2013, Robinson and Atkinson, 2013, Shen et al., 2013, Sopko and Perrimon, 2013, Southall et al., 2013, Xiong et al., 2013, Yu et al., 2013, Butchar et al., 2012, Foronda et al., 2012, Jeon et al., 2012, Lim et al., 2012, Mackay et al., 2012, Simakov et al., 2012, Weber et al., 2012, Whitworth et al., 2012, Biteau and Jasper, 2011, Dworkin et al., 2011, Eddison et al., 2011, Friedman et al., 2011, Galindo et al., 2011, Garcia and Stathopoulos, 2011, Hwang and Rulifson, 2011, Jiang et al., 2011, Kamakura, 2011, Karim and Moore, 2011, Letizia et al., 2011, Losick et al., 2011, Matta et al., 2011, Mirkovic et al., 2011, Mukai et al., 2011, Murillo-Maldonado et al., 2011, Nicholson et al., 2011, Sinenko et al., 2011, Sinenko et al., 2011, Sun et al., 2011, Weyers et al., 2011, Zettl et al., 2011, Zhang et al., 2011, Ashton-Beaucage et al., 2010, Bernard et al., 2010, Campos et al., 2010, Dilks and DiNardo, 2010, Djiane and Mlodzik, 2010, Haberman et al., 2010, Ho et al., 2010, Ichikawa et al., 2010, Kim et al., 2010, Kitadate and Kobayashi, 2010, Rendina et al., 2010, Ren et al., 2010, Salzer et al., 2010, Wang et al., 2010, Wasbrough et al., 2010, Yamashita et al., 2010, Yan et al., 2010, Aerts et al., 2009, Almudi et al., 2009, Birkholz et al., 2009, Donlea et al., 2009, Fetting et al., 2009, Huh et al., 2009, Jiang and Edgar, 2009, Krejcí et al., 2009, Oishi et al., 2009, Shen et al., 2009, Tan et al., 2009, Wu et al., 2009, Yan et al., 2009, Yan et al., 2009, Zhang et al., 2009, Chen et al., 2008, Christensen et al., 2008.12.28, Kim et al., 2008, Larson et al., 2008, Lyulcheva et al., 2008, Melicharek et al., 2008, Seibert et al., 2008, Tien et al., 2008, Wang et al., 2008, Weber et al., 2008, Xia et al., 2008, Yakoby et al., 2008, Beltran et al., 2007, Bennett and Lyulcheva, 2007, Bernardi et al., 2007, Bianco et al., 2007, Brown et al., 2007, Chang et al., 2007, Chen et al., 2007, Christensen et al., 2007.10.29, de Navascués and Modolell, 2007, Gonzalez et al., 2007, Goodfellow et al., 2007, Haerty et al., 2007, Halfon and Leatherbarrow, 2007, Kim et al., 2007, Majumdar and Marenda, 2007, Nishimura et al., 2007, Nurminsky, 2007, O'Keefe et al., 2007, Orian et al., 2007, Overton et al., 2007, Sarkar et al., 2007, Schwartz and Pirrotta, 2007, Seibert et al., 2007, Tajiri et al., 2007, Tien et al., 2007, Tseng et al., 2007, Vrailas-Mortimer et al., 2007, Abdu et al., 2006, Atkey et al., 2006, Brodu and Casanova, 2006, Brown et al., 2006, Cela and Llimargas, 2006, Chen and Schupbach, 2006, Hannan et al., 2006, Hashimoto and Yamaguchi, 2006, Jones et al., 2006, Martin-Pena et al., 2006, Mirkovic and Mlodzik, 2006, Oishi et al., 2006, Pai et al., 2006, Sandmann et al., 2006, Slawson et al., 2006, Vrailas and Moses, 2006, Wahlstrom et al., 2006, Wang et al., 2006, Baonza and Freeman, 2005, Firth and Baker, 2005, Goering and Gibson, 2005, Jordan et al., 2005, Kristiansen et al., 2005, Palsson et al., 2005, Papadia et al., 2005, Rodrigues et al., 2005, Roederer et al., 2005, Xie et al., 2005, Angulo et al., 2004, Baker, 2004, Brodu et al., 2004, Bruckner et al., 2004, Bruckner et al., 2004, Geiger-Thornsberry and Mackay, 2004, MacDougall et al., 2004, Meignin et al., 2004, Rawlings et al., 2004, Schlesinger et al., 2004, Chang et al., 2003, Chang et al., 2001, Duchek and Rorth, 2001, Pickeral et al., 2000, Robertson et al., 2000, Vinos and Freeman, 2000, Lee et al., 1999)
El
HD-33
Torpedo/Egfr
l(2)57EFa
l(2)57Ea
top
(Balaji et al., 2019, Sriskanthadevan-Pirahas et al., 2018, Matsuda et al., 2015, Matsuda et al., 2015, Bhattacharya and Baker, 2011, Almudi et al., 2009, Baker et al., 2009, Witte et al., 2009, Chang et al., 2008, Galindo et al., 2005, Jekely et al., 2005, Wilson et al., 2005, Jordan et al., 2004, Meignin et al., 2004, del Alamo et al., 2002, Smith et al., 2002, Yang and Baker, 2001, Garoia et al., 2000, Gigliotti et al., 2000, Grammont et al., 2000, Kumar and Moses, 2000, Baonza and Garcia-Bellido, 1999, Hummel et al., 1999, de Celis, 1998, Roch et al., 1998, Silver et al., 1998, Cifuentes and Garcia-Bellido, 1997, de Celis et al., 1997, Lim et al., 1997, Newmark et al., 1997, Queenan et al., 1997, Schnorr and Berg, 1997, Scholz et al., 1997, Scholz et al., 1997, Thio et al., 1997, Zhao and Bownes, 1997, Kraut and Campos-Ortega, 1996, Morimoto et al., 1996, Schnorr and Berg, 1996, Thio and Schupbach, 1996, de Celis et al., 1995, Gonzalez-Reyes et al., 1995, Gonzalez-Reyes et al., 1995, Hong and Hashimoto, 1995, Madhavan and Madhavan, 1995, Morisato and Anderson, 1995, Munn and Steward, 1995, Simmerl et al., 1995, Stein, 1995, Brand and Perrimon, 1994, Christerson and McKearin, 1994, Clifford and Schupbach, 1994, de Celis and Garcia-Bellido, 1994, Diaz-Benjumea and Hafen, 1994, Roth and Schupbach, 1994, Schupbach and Roth, 1994, St. Johnston, 1994, Chasan and Anderson, 1993, Forlani et al., 1993, Martinez Arias, 1993, Clifford and Schupbach, 1992, Garcia-Bellido and de Celis, 1992, Govind and Steward, 1991, Held, 1991, Madhavan et al., 1991, Shilo and Raz, 1991, Diaz-Benjumea and Garcia-Bellido, 1990, Pawson and Bernstein, 1990, Clifford and Schupbach, 1989, Manseau and Schupbach, 1989, Price et al., 1989)
top/flb
torpedo/Egfr
torpedo/egfr
Name Synonyms
Drosophila epidermal growth factor receptor
Drosophila epidermal growth factor receptor homologue
Ellipse torpedo
Epidermal growth factor Receptor
morphological defects 1
Secondary FlyBase IDs
  • FBgn0010599
  • FBgn0022793
Datasets (1)
Study focus (1)
Experimental Role
Project
Project Type
Title
  • bait_protein
Interaction map generated by purification of receptor tyrosine kinase pathway factors, with identification of copurifying proteins by mass spectrometry.
Study result (0)
Result
Result Type
Title
External Crossreferences and Linkouts ( 1703 )
Sequence Crossreferences
NCBI Gene - Gene integrates information from a wide range of species. A record may include nomenclature, Reference Sequences (RefSeqs), maps, pathways, variations, phenotypes, and links to genome-, phenotype-, and locus-specific resources worldwide.
GenBank Nucleotide - A collection of sequences from several sources, including GenBank, RefSeq, TPA, and PDB.
GenBank Protein - A collection of sequences from several sources, including translations from annotated coding regions in GenBank, RefSeq and TPA, as well as records from SwissProt, PIR, PRF, and PDB.
RefSeq - A comprehensive, integrated, non-redundant, well-annotated set of reference sequences including genomic, transcript, and protein.
UniProt/GCRP - The gene-centric reference proteome (GCRP) provides a 1:1 mapping between genes and UniProt accessions in which a single 'canonical' isoform represents the product(s) of each protein-coding gene.
UniProt/Swiss-Prot - Manually annotated and reviewed records of protein sequence and functional information
UniProt/TrEMBL - Automatically annotated and unreviewed records of protein sequence and functional information
Other crossreferences
AlphaFold DB - AlphaFold provides open access to protein structure predictions for the human proteome and other key proteins of interest, to accelerate scientific research.
BDGP expression data - Patterns of gene expression in Drosophila embryogenesis
DRscDB - A single-cell RNA-seq resource for data mining and data comparison across species
EMBL-EBI Single Cell Expression Atlas - Single cell expression across species
FlyAtlas2 - A Drosophila melanogaster expression atlas with RNA-Seq, miRNA-Seq and sex-specific data
FlyMine - An integrated database for Drosophila genomics
KEGG Genes - Molecular building blocks of life in the genomic space.
MARRVEL_MODEL - MARRVEL (model organism gene)
PDB - An information portal to biological macromolecular structures
Linkouts
BioGRID - A database of protein and genetic interactions.
Drosophila Genomics Resource Center - Drosophila Genomics Resource Center (DGRC) cDNA clones
DroID - A comprehensive database of gene and protein interactions.
DRSC - Results frm RNAi screens
Eukaryotic Promoter Database - A collection of databases of experimentally validated promoters for selected model organisms.
FlyAtlas - Adult expression by tissue, using Affymetrix Dros2 array
FlyCyc Genes - Genes from a BioCyc PGDB for Dmel
Fly-FISH - A database of Drosophila embryo and larvae mRNA localization patterns
Flygut - An atlas of the Drosophila adult midgut
FlyMet - A comprehensive tissue-specific metabolomics resource for Drosophila.
iBeetle-Base - RNAi phenotypes in the red flour beetle (Tribolium castaneum)
Interactive Fly - A cyberspace guide to Drosophila development and metazoan evolution
KEGG Pathways - A collection of manually drawn pathway maps representing knowledge of molecular interaction, reaction and relation networks.
MIST (genetic) - An integrated Molecular Interaction Database
MIST (protein-protein) - An integrated Molecular Interaction Database
SignaLink - A signaling pathway resource with multi-layered regulatory networks.
References (2,038)